Company / Operating Cash Flow per Share
Amphstar Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.28
FY2025
5-year range
$1.87 / $4.44
FY2021-FY2025
Trend
-26.1%
vs FY2024
Sector context
#31 of 212
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s operating cash flow per share of $3.28 is higher than 85% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.82 in FY2018 to $4.44 in FY2024.
Based on SEC 10-K filings.
3.28 in FY2025 with a 5-year CAGR of +21.7%. Top quartile in the Health Care sector.
Declined from $3.81 to $3.28 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
+122.3% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 26.1% year-over-year.
- Ranks #31 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.28 | -26.1% |
| FY2024 | $4.44 | +16.4% |
| FY2023 | $3.81 | +104.1% |
| FY2022 | $1.87 | -9.4% |
| FY2021 | $2.06 | +67.8% |
| FY2020 | $1.23 | +37.3% |
| FY2019 | $0.90 | +9.3% |
| FY2018 | $0.82 | -3.4% |
| FY2017 | $0.85 | -0.6% |
| FY2016 | $0.85 | +256.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026